
Xiaobu Ye, MD, MS
Highlights
Languages
- English
Gender
FemaleJohns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Xiaobu Ye
Primary Academic Title
Professor of Neurological Surgery
Background
Xiaobu Ye is a Professor of Neurosurgery and Oncology/Biostatistics at the Johns Hopkins School of Medicine (JHMI), the Director of Biostatistics in the Department of Neurosurgery. She earned her degrees in medicine and an MS in Biostatistics in 1983 and 1994, respectively. She was a faculty member at the Medical University of South Carolina before joining the Division of Oncology Biostatistics at JHMI in 2002.
The main focus of her work has been implementing statistical methods in practical clinical research with an emphasis in clinical trials, relying heavily on scientific rationales in medicine, biology, and principles of statistics. Statistical methods include the continual reassessment method (CRM), the response surface method, an entropy-based approach, the Bayesian method, and other general statistical approaches to anti-cancer therapeutic development.
Dr. Ye also served as a Senior Statistician for the Center for Complementary and Alternative Medicine and SPORE grants at Johns Hopkins. She served as the biostatistician for an NIH-founded Adult Brain Tumor Consortium (ABTC) for over 20 years, the formal Chair of Biostatistics of the Consortium. She also served as an elected member of the National Cancer Institution Brain Malignancies Steering Committee for over a decade and the Head and Neck Steering Committee's Metastatic-Recurrent Task Force for Biostatistics.
She has more than 30 years of experience in application of statistical principles in medical, translational, and especially neurological diseases research and clinical trials.
Centers and Institutes
Additional Academic Titles
Professor of Oncology
Selected Publications
- Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma. Bow H, Hwang LS, Schildhaus N, Xing J, Murray L, Salditch Q, Ye X, Zhang Y, Weingart J, Brem H, Tyler B. J Neurosurg. 2014 Mar;120(3):662-9. doi: 10.3171/2013.11.JNS13556. Epub 2013 Dec 20. PMID: 24359008
- Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, Hernandez-Hermann M, Gomez L, Ye X, Weingart JD, Olivi A, Blakeley J, Gallia GL, Lim M, Brem H, Quinones-Hinojosa A. Neuro Oncol. 2014 Jan;16(1):113-22. doi: 10.1093/neuonc/not137. Epub 2013 Nov 26. PMID: 24285550
- Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer. Campian JL, Sarai G, Ye X, Marur S, Grossman SA. Head Neck. 2013 Oct 31. doi: 10.1002/hed.23535. [Epub ahead of print] PMID: 24174270
- Impact on seizure control of surgical resection or radiosurgery for cerebral arteriovenous malformations. Wang JY, Yang W, Ye X, Rigamonti D, Coon AL, Tamargo RJ, Huang J. Neurosurgery. 2013 Oct;73(4):648-55; discussion 655-6. doi: 10.1227/NEU.0000000000000071. PMID: 23842554
- Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study. Cimino-Mathews A, Ye X, Meeker A, Argani P, Emens LA.Hum Pathol. 2013 Oct;44(10):2055-63. doi: 10.1016/j.humpath.2013.03.010. Epub 2013 May 21. PMID: 23701942